Dr Barb Paldus is an Endocrinologist and Senior Clinical Research Fellow with the University of Melbourne and St Vincent’s Hospital Diabetes Technology Research Group, and has consultancy roles at Western Health, Mercy Health and the Royal Melbourne Hospital. Barb has special clinical and research interests in the application of diabetes technologies to the management of type 1 diabetes particularly during exercise, having completed a PhD at the University of Melbourne, focusing on advancing automated insulin delivery and other innovative technologies for optimal type 1 diabetes management during exercise.

Anthony Zimmermann has been working as a senior staff Specialist at the Lyell McEwin Hospital, Elizabeth Vale, Adelaide since 2003. He has been the Head of Diabetes and Endocrine Services, Northern Adelaide Local Health Network (NALHN) since 2013. He holds a Clinical Associate Professor title in the Department of Medicine at the University of Adelaide. He is an enthusiastic mentor for undergraduate and postgraduate medical trainees and has earned citations for excellence in clinical teaching. He is a Principal Investigator for the Australian National Diabetes Inpatient Audit (AusNaDIA) and Australian Diabetes Clinical Quality Registry (ADCQR) Scientific Advisory Committee member.

Prof Davis is Chief Investigator of the landmark Fremantle Diabetes Study, a community-based observational study of diabetes care, control and complications which has been running since 1993.

Prof Davis is Chief Investigator of the landmark Fremantle Diabetes Study which started with Phase I in 1993 and continues through Phase II (recruitment 2008-2011) - these studies have involved around 3,000 participants followed for up to 33 years

Dr Jennifer Snaith is a St Vincent’s Hospital Staff Specialist Endocrinologist and post-doctoral researcher at the Victor Chang Cardiac Research Institute and the University of New South Wales. She leads type 1 diabetes clinical trials testing the potential for adjunctive therapies to improve cardiometabolic health in type 1 diabetes.

Melissa H. Lee, MBBS(Hons) FRACP PhD, is an endocrinologist and Senior Clinical Research Fellow at the University of Melbourne and St Vincent’s Hospital. Her research focuses on type 1 diabetes pathophysiology and technology, alongside leading clinical services at Werribee Mercy Hospital and contributing extensively to national diabetes education and research.

Professor Dr Muhammad Yazid Jalaludin is The Deputy Dean and a Professor of Paediatrics at the Faculty of Medicine, Universiti Malaya. He practices as a Senior Consultant Paediatrician and Senior Consultant Paediatric Endocrinologist at the University Malaya Medical Centre and University Malaya Specialist Centre.

Dr Ella Zomer is a Senior Research Fellow at Monash University. She is the Diabetes and Cardiovascular Disease Program Lead in the Monash University Health Economics Group and Research Lead of the Australian Diabetes Clinical Quality Registry. Her research interest lies in clinical epidemiology and health economics.

Dr. Timor Glatzer, Clinical Development and Diabetes Indication Lead at Roche Diabetes Care, holds a PhD in immunology following research at the Leibniz Institute and Charité Berlin. He specializes in AI-driven CGM technology, having published extensively on CGM-based diabetes management and innovative digital solutions to improve clinical outcomes for patients.

Dr. Chirath Hettiarachchi, PhD, is a Research Fellow in the School of Computing at The Australian National University, where he develops artificial intelligence methods for personalised closed-loop healthcare interventions. His work focuses on reinforcement learning for automated insulin delivery in type 1 diabetes and AI-guided transcranial brain stimulation for depression